机译:Thoracic Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Sotorasib: Subgroup Analysis of Phase II Trial Shows Activity With Breakthrough KRAS Inhibitor in Lung Cancer, By Alice Goodman
机译:Issues in Oncology: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Study Finds Income Eligibility Limits for Medicaid May Be Associated With Worse Long-Term Survival Among Newly Diagnosed Patients With Cancer, By Jo Cavallo
机译:Other Solid Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Novel Monoclonal Antibody Emerges as Potential First-Line Standard in Nasopharyngeal Cancer, By Caroline Helwick
机译:Genitourinary (Non-Prostate) Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: KEYNOTE-564: Adjuvant Pembrolizumab Extends Disease-Free Survival in High-Risk Renal Cell Carcinoma, By Alice Goodman
机译:Thoracic Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: NSCLC: Nivolumab, Ipilimumab, and Chemotherapy for Advanced Disease, By The ASCO Post Staff
机译:Melanoma: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: High-Dose Interferon or Ipilimumab vs Pembrolizumab for High-Risk Resected Melanoma, By The ASCO Post Staff
机译:Gastrointestinal Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective:Trastuzumab Deruxtecan Shows Activity in Patients With Advanced HER2-Expressing Metastatic Colorectal Cancer, By JADPRO Staff
机译:Gastrointestinal Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Liposomal Irinotecan With 5-FU and Leucovorin Improves Outcomes for Patients With Biliary Tract Cancer, By JADPRO Staff
机译:Melanoma: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Targeting LAG-3 and PD-1 With Relatlimab and Nivolumab: A New Option Under Study in Advanced Melanoma, By Caroline Helwick
机译:Issues in Oncology: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Results of a Restrictive Opioid Prescription Protocol for Patients With Cancer Undergoing Surgery, By Jo Cavallo
机译:Gynecologic Cancers: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Bevacizumab in Advanced Ovarian Cancer: Phase III Trial Finds More Is Not Better, By Caroline Helwick
机译:Prostate Cancer: 2021 ASCO Annual Meeting Highlights for the Advanced Practitioner: The Advanced Practitioner Perspective: Prostate Cancer: Androgen-Deprivation Therapy With Orteronel or Bicalutamide, By The ASCO Post Staff